Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Oesophago-gastric Cancer × Oxaliplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 391 Stomach Neoplasms 267 Rectal Neoplasms 243 Colonic Neoplasms 180 Pancreatic Neoplasms 154 Neoplasm Metastasis 96 Esophageal Neoplasms 80 Neoplasms 62 Carcinoma, Hepatocellular 53 Adenocarcinoma Of Esophagus 43 Adenocarcinoma 42 Lymphoma, Large B-Cell, Diffuse 41 Cholangiocarcinoma 38 Carcinoma, Non-Small-Cell Lung 36 Biliary Tract Neoplasms 30 Gallbladder Neoplasms 26 Gastrointestinal Neoplasms 25 Recurrence 24 Liver Neoplasms 24 Esophageal Squamous Cell Carcinoma 21 Breast Neoplasms 21 Ovarian Neoplasms 19 Bile Duct Neoplasms 17 Unspecified Adult Solid Tumor, Protocol Specific 15 Peritoneal Neoplasms 15 Appendiceal Neoplasms 11 Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Lymphoma, Non-Hodgkin 10 Lung Neoplasms 10 Locally Advanced Rectal Cancer 10

Interventions

Panitumumab 1 Oxaliplatin 1 Epirubicin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00824785 2012-12-11

REAL3

Royal Marsden NHS Foundation Trust

Phase 3 Terminated

Gastrointestinal

Oesophago-gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡